Search Results

Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs.

• Authors : Xie, Dafei¹ (AUTHOR); He, Song¹ (AUTHOR); Han, Lu² (AUTHOR)

Subjects: HUMAN herpesvirus 1; DRUG target; VIRUS diseases

• Source: Briefings in Bioinformatics. May2022, Vol. 23 Issue 3, p1-15. 15p.

Record details

Recent advancements in HIV/AIDS treatment.

• Authors : Kutzer, Dolores¹; Hicks, Megan²; Hlebik, Erin²

Subjects: HIV; AIDS; DISEASE risk factors

• Source: Drug Topics. 4/14/2008, Vol. 152 Issue 5, p54-63. 10p. 2 Charts.

Record details

Whatever happened to...? Helium Shortage • Cytokine Storm • Martian Dust Threat • Novel HIV Drug.

• Authors : Basu, Sourish

Subjects: *SUPPLY & demand; HELIUM; MAGNETIC resonance imagingPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

• Source: Scientific American. Oct2007, Vol. 297 Issue 4, p18-18. 1p.

Record details

New HIV drug first to target CCR5 receptor.

• Authors : Belden, Heidi

Subjects: CHEMOKINES; THERAPEUTICSPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

• Source: Drug Topics. 9/3/2007, Vol. 151 Issue 17, p12-12. 3/4p.

Record details

First-in-class CCR5 inhibitor OK'd.

Subjects: PFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

• Source: Drug Topics. 8/20/2007, Vol. 151 Issue 16, p6-6. 1/6p.

Record details